JANX vs XLE
Janux Therapeutics Inc (JANX) versus Energy Select Sector SPDR® Fund (XLE) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Energy Select Sector SPDR® Fund (XLE) common stock listed on US.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
XLE does not have a complete income-statement cache yet.
JANX currently screens at market cap $1.49B. XLE currently screens at market cap $0.
Not investment advice. Open the JANX and XLE stock pages for the full models.
Not investment advice.